Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer

Peer Review reports

Original Submission
26 Jan 2013	Submitted	Original manuscript
28 Feb 2013	Reviewed	Reviewer Report - Kathleen Pritchard
5 Mar 2013	Reviewed	Reviewer Report - Anthony Fyles
31 Mar 2013	Author responded	Author comments - Hirotaka Iwase
Resubmission - Version 2
31 Mar 2013	Submitted	Manuscript version 2
6 May 2013	Reviewed	Reviewer Report - Anthony Fyles
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
12 May 2013	Editorially accepted
16 May 2013	Article published	10.1186/1471-2407-13-239

Back to article page